• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子的治疗性调控:转化生长因子β-1可保护接受致死剂量阿糖胞苷治疗的小鼠。

Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine.

作者信息

Pierce D F, Coffey R J

机构信息

Dept. of Surgery, Vanderbilt School of Medicine, Nashville, TN 37232-2730.

出版信息

Am Surg. 1994 Jan;60(1):18-25.

PMID:8273969
Abstract

We have developed a mouse model to utilize the specific regulatory effects of Transforming Growth Factor Beta-1 (TGF beta 1), the prototype for a family of growth inhibitory cytokines. A vital factor in the regulation of normal cellular growth for many cell types, TGF beta 1 prevents proliferation by reversibly arresting cells at the G1/S border of the cell cycle, thus delaying DNA synthesis and cell division. Since the dose of cytotoxic chemotherapy is limited by its adverse effects on bone marrow and gut cells, we proposed that a TGF beta 1-induced block at G1/S would diminish the S phase toxicity of high dose cytarabine (ara-C). The dosage of ara-C required to kill 90 per cent of 4-week old DBA/2 males was determined to be 3200 mg/kg every 12 hours x 2. Pretreatment with TGF beta 1 6-24 hours before the first dose of ara-C proved to be significantly protective; 8/9 TGF beta 1-pretreated mice survived versus 1/9 treated with TGF beta 1 for 3 hours or less or with ara-C alone (chi2 = 10.89 P = 0.001). A second experiment confirmed this effect; TGF beta 1 pretreatment for 6-24 hours protected 9/9 versus 0/9 survivors in the group treated with TGF beta 1 for 3 hours or less or with ara-C alone (chi2 = 18.0, P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们构建了一种小鼠模型,以利用转化生长因子β-1(TGFβ1)的特定调节作用,TGFβ1是生长抑制细胞因子家族的原型。作为许多细胞类型正常细胞生长调节中的一个重要因子,TGFβ1通过使细胞在细胞周期的G1/S边界可逆性停滞来阻止增殖,从而延迟DNA合成和细胞分裂。由于细胞毒性化疗的剂量受其对骨髓和肠道细胞的不良反应限制,我们提出TGFβ1诱导的G1/S期阻滞会降低高剂量阿糖胞苷(ara-C)的S期毒性。杀死90%的4周龄DBA/2雄性小鼠所需的ara-C剂量确定为每12小时3200mg/kg,共2次。在首次给予ara-C前6 - 24小时用TGFβ1预处理显示出显著的保护作用;8/9经TGFβ1预处理的小鼠存活,而在TGFβ1处理3小时或更短时间或仅用ara-C处理的小鼠中,存活的为1/9(χ2 = 10.89,P = 0.001)。第二项实验证实了这一效果;在TGFβ1处理3小时或更短时间或仅用ara-C处理的组中,经6 - 24小时TGFβ1预处理的小鼠有9/9存活,而未预处理的组无存活(χ2 = 18.0,P < 0.001)。(摘要截短为250字)

相似文献

1
Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine.细胞因子的治疗性调控:转化生长因子β-1可保护接受致死剂量阿糖胞苷治疗的小鼠。
Am Surg. 1994 Jan;60(1):18-25.
2
Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.转化生长因子β1可全身性调节小鼠的粒细胞、红细胞、淋巴细胞和血小板细胞。
Exp Hematol. 1992 Sep;20(8):943-50.
3
Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.高剂量1-β-D-阿拉伯呋喃糖基胞嘧啶注射间隔对大鼠急性髓性白血病模型中白血病细胞负荷、肠道毒性及正常造血干细胞的影响
Cancer Res. 1986 Aug;46(8):3825-7.
4
Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription.转化生长因子β1在G1期晚期抑制小鼠角质形成细胞,且与对基因转录的影响无关。
Cancer Res. 1995 Sep 1;55(17):3928-32.
5
[Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].[血小板因子4作为造血前体细胞的抑制剂和保护剂:可能的作用机制]
Shi Yan Sheng Wu Xue Bao. 1995 Dec;28(4):415-26.
6
Inhibition of hepatocyte DNA synthesis by transforming growth factor beta 1 and cyclic AMP: effect immediately before the G1/S border.转化生长因子β1和环磷酸腺苷对肝细胞DNA合成的抑制作用:在G1/S边界之前的即时效应。
Cancer Res. 1992 Jul 1;52(13):3598-603.
7
Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
Cancer Res. 1990 Jan 15;50(2):328-32.
8
The chemokine CCL21 protects normal marrow progenitors from Ara-C cytotoxicity.趋化因子CCL21可保护正常骨髓祖细胞免受阿糖胞苷的细胞毒性作用。
Cancer Chemother Pharmacol. 2002 Aug;50(2):163-6. doi: 10.1007/s00280-002-0486-7. Epub 2002 Jun 27.
9
Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation.转化生长因子-β在小鼠早期胚胎中的作用:对肌肉形成和着床调控的影响
Dev Genet. 1993;14(3):212-24. doi: 10.1002/dvg.1020140308.
10
Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
Cancer Res. 1983 Jul;43(7):3192-6.

引用本文的文献

1
Therapeutic implications of the TGF-beta system.转化生长因子-β系统的治疗意义。
J Mammary Gland Biol Neoplasia. 1996 Oct;1(4):391-7. doi: 10.1007/BF02017395.
2
Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells.转化生长因子β1减轻神经酰胺诱导的人白血病HL-60细胞中CPP32/Yama的激活及凋亡。
Biochem J. 1997 Nov 1;327 ( Pt 3)(Pt 3):663-7. doi: 10.1042/bj3270663.